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Supplementary Figures: 
 
 
 
 
Supplementary Figure 1. Increase in aneuploidy following reversine treatment 
detected by FISH. Blastomeres were classified as normal or aneuploid based on 
FISH analysis for chromosomes 2, 11 and 16. Reversine-treated cells (n = 1076) had 
significantly higher rates of aneuploidy than controls (n = 1376; *** p < 0.001, χ2) 
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Supplementary Figure 2. Decreased Mad2 mRNA expression following zygote 
injection of Mad2 siRNA. Zygotes were injected with siRNA and mRNA expression 
assessed by RT-qPCR 48 hours later at the eight-cell stage (Mad2 siRNA n = 51 
embryos, control siRNA n = 54 embryos, 4 independent experiments). Error bars = 
s.e.m. 
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Supplementary Figure 3. Development of chimeric mosaic embryos to birth. 1:1 
Reversine chimeras (n = 26) were transferred to foster mothers, resulting in the birth 
of 13 live pups.  
Figure'S4'
Supplementary Tables: 
 
Supplementary Table 1. Reversine-treated embryos bypass Nocodazole-induced 
metaphase arrest. 
 
 Arrest and fragment Divide normally Divided (total) 
Control 22 0 0% (22) 
Reversine 0.5µM 13 13 50% (26) 
Reversine 1.0µM 9 17 65% (26) 
 
 
 
 
Supplementary Table 2. Newborn weights of chimeric mosaic pups. 
Pup Weight (g) 
1 3.4 
2 3.4 
3 3.2 
4 3.5 
5 3.4 
6 3.3 
7 3.5 
8 3.2 
9 3.0 
10 3.7 
11 2.6 
12 3.4 
13 3.4 								
	
